Skip to main content
Erschienen in: Supportive Care in Cancer 8/2019

14.12.2018 | Original Article

A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life

verfasst von: Wen-Chi Chou, Jen-Shi Chen, Chia-Yen Hung, Chang-Hsien Lu, Yu-Yun Shao, Tzeon-Jye Chiou, Yung-Chuan Sung, Kun-Ming Rau, Chia-Jui Yen, Su-Peng Yeh, Ta-Chih Liu, Ming-Fang Wu, Ming-Yang Lee, Ming-Sun Yu, Wen-Li Hwang, Pang-Yu Lai, Cheng-Shyong Chang, Ruey-Kuen Hsieh

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Poor adherence to analgesic drugs is one of the most common barriers to adequate pain management. This prospective, cross-sectional, patient-oriented observational study aimed to explore the adherence rate, clinical factors, and impact of adherence to analgesic drugs on the quality of life (QoL) among cancer outpatients in Taiwan.

Methods

Eight hundred ninety-seven consecutive adult outpatients with cancer who had reported tumor pain and received regular analgesic drug treatment were enrolled from 16 medical centers across Taiwan. The Brief Pain Inventory was used to assess pain intensity and QoL. Morisky’s four-item medication adherence scale was used to assess adherence to analgesic drugs. Clinical factors possibly associated with good adherence to analgesic drugs were analyzed using multivariate logistic regression analyses.

Results

Of the 897 patients, 26.9% met criteria for the good, 35.5% for the moderate, and 37.6% for the poor adherence groups. The good adherence group had significantly better QoL outcomes than the moderate and poor adherence groups (all p < 0.05). Age ≥ 50 years, head and neck or hematological malignancies, cancer-related pain, patients who agreed or strongly agreed that the side effects of analgesic drugs were tolerable, and patients who disagreed or strongly disagreed that the dosing schedule could be flexibly self-adjusted to deal with the actual pain were predictors of good adherence to analgesic drugs.

Conclusions

Awareness of the clinical factors associated with adherence to analgesic drugs may help clinicians to identify cancer patients at a greater risk of non-adherence, reinforce optimal pain management, and improve the QoL by enhancing adherence to pain medications.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. Pain 132(3):312–320CrossRefPubMed van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. Pain 132(3):312–320CrossRefPubMed
2.
Zurück zum Zitat van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18(9):1437–1449CrossRefPubMed van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18(9):1437–1449CrossRefPubMed
3.
Zurück zum Zitat Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manag 34(1):94–104CrossRef Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manag 34(1):94–104CrossRef
4.
Zurück zum Zitat Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, de Conno F, Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M, Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D, Zeppetella G (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13(2):e58–e68CrossRef Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, de Conno F, Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M, Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D, Zeppetella G (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13(2):e58–e68CrossRef
5.
Zurück zum Zitat Ripamonti CI, Bandieri E, Roila F, ESMO Guidelines Working Group (2011) Management of cancer pain: ESMO clinical practice guidelines. In: Ann Oncol 22 Suppl 6:vi69–77 Ripamonti CI, Bandieri E, Roila F, ESMO Guidelines Working Group (2011) Management of cancer pain: ESMO clinical practice guidelines. In: Ann Oncol 22 Suppl 6:vi69–77
6.
Zurück zum Zitat Greco MT, Roberto A, Corli O, Deandrea S, Bandieri E, Cavuto S, Apolone G (2014) Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol 32(36):4149–4154CrossRefPubMed Greco MT, Roberto A, Corli O, Deandrea S, Bandieri E, Cavuto S, Apolone G (2014) Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol 32(36):4149–4154CrossRefPubMed
7.
Zurück zum Zitat Deandrea S, Montanari M, Moja L, Apolone G (2008) Prevalence of under-treatment in cancer pain. A review of published literature. Ann Oncol 19(12):1985–1991CrossRefPubMedPubMedCentral Deandrea S, Montanari M, Moja L, Apolone G (2008) Prevalence of under-treatment in cancer pain. A review of published literature. Ann Oncol 19(12):1985–1991CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Hsieh RK (2005) Pain control in Taiwanese patients with cancer: a multicenter, patient-oriented survey. J Formos Med Assoc 104(12):913–919PubMed Hsieh RK (2005) Pain control in Taiwanese patients with cancer: a multicenter, patient-oriented survey. J Formos Med Assoc 104(12):913–919PubMed
10.
Zurück zum Zitat Rau KM, Chen JS, Wu HB, Lin SF, Lai MK, Chow JM, Huang ML, Wang CJ, Tai CJ, Hwang WL, Lu YC, Chan CH, Hsieh RK (2015) The impact of pain control on physical and psychiatric functions of cancer patients: a nation-wide survey in Taiwan. Jpn J Clin Oncol 45(11):1042–1049CrossRefPubMedPubMedCentral Rau KM, Chen JS, Wu HB, Lin SF, Lai MK, Chow JM, Huang ML, Wang CJ, Tai CJ, Hwang WL, Lu YC, Chan CH, Hsieh RK (2015) The impact of pain control on physical and psychiatric functions of cancer patients: a nation-wide survey in Taiwan. Jpn J Clin Oncol 45(11):1042–1049CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Shen WC, Chen JS, Shao YY, Lee KD, Chiou TJ, Sung YC, Rau KM, Yen CJ, Liao YM, Liu TC, Wu MF, Lee MY, Yu MS, Hwang WL, Lai PY, Chang CS, Chou WC, Hsieh RK (2017) Impact of undertreatment of cancer pain with analgesic drugs on patient outcomes: a nationwide survey of outpatient cancer patient care in Taiwan. J Pain Symptom Manag 54(1):55–65CrossRef Shen WC, Chen JS, Shao YY, Lee KD, Chiou TJ, Sung YC, Rau KM, Yen CJ, Liao YM, Liu TC, Wu MF, Lee MY, Yu MS, Hwang WL, Lai PY, Chang CS, Chou WC, Hsieh RK (2017) Impact of undertreatment of cancer pain with analgesic drugs on patient outcomes: a nationwide survey of outpatient cancer patient care in Taiwan. J Pain Symptom Manag 54(1):55–65CrossRef
12.
Zurück zum Zitat Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S (2001) Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 93(3):247–257CrossRefPubMed Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S (2001) Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 93(3):247–257CrossRefPubMed
13.
Zurück zum Zitat Jamison RN, Sheehan KA, Scanlan E, Matthews M, Ross EL (2014) Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers. J Opioid Manag 10(6):375–382CrossRefPubMed Jamison RN, Sheehan KA, Scanlan E, Matthews M, Ross EL (2014) Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers. J Opioid Manag 10(6):375–382CrossRefPubMed
14.
Zurück zum Zitat Potter VT, Wiseman CE, Dunn SM, Boyle FM (2003) Patient barriers to optimal cancer pain control. Psychooncology 12(2):153–160CrossRefPubMed Potter VT, Wiseman CE, Dunn SM, Boyle FM (2003) Patient barriers to optimal cancer pain control. Psychooncology 12(2):153–160CrossRefPubMed
15.
Zurück zum Zitat Liang SY, Yates P, Edwards H, Tsay SL (2008) Factors influencing opioid-taking self-efficacy and analgesic adherence in Taiwanese outpatients with cancer. Psychooncology 17(11):1100–1107CrossRefPubMed Liang SY, Yates P, Edwards H, Tsay SL (2008) Factors influencing opioid-taking self-efficacy and analgesic adherence in Taiwanese outpatients with cancer. Psychooncology 17(11):1100–1107CrossRefPubMed
16.
Zurück zum Zitat Lin CC (2000) Barriers to the analgesic management of cancer pain: a comparison of attitudes of Taiwanese patients and their family caregivers. Pain 88(1):7–14CrossRefPubMed Lin CC (2000) Barriers to the analgesic management of cancer pain: a comparison of attitudes of Taiwanese patients and their family caregivers. Pain 88(1):7–14CrossRefPubMed
17.
Zurück zum Zitat Gunnarsdottir S, Donovan HS, Serlin RC, Voge C, Ward S (2002) Patient-related barriers to pain management: the Barriers Questionnaire II (BQ-II). Pain 99(3):385–396CrossRefPubMed Gunnarsdottir S, Donovan HS, Serlin RC, Voge C, Ward S (2002) Patient-related barriers to pain management: the Barriers Questionnaire II (BQ-II). Pain 99(3):385–396CrossRefPubMed
18.
Zurück zum Zitat Lee BO, Liu Y, Wang YH, Hsu HT, Chen CL, Chou PL, Hsu WC (2015) Mediating effect of family caregivers’ hesitancy to use analgesics on homecare cancer patients' analgesic adherence. J Pain Symptom Manag 50(6):814–821CrossRef Lee BO, Liu Y, Wang YH, Hsu HT, Chen CL, Chou PL, Hsu WC (2015) Mediating effect of family caregivers’ hesitancy to use analgesics on homecare cancer patients' analgesic adherence. J Pain Symptom Manag 50(6):814–821CrossRef
19.
Zurück zum Zitat Corli O, Montanari M, Deandrea S, Greco MT, Villani W, Apolone G (2012) An exploratory analysis on the effectiveness of four strong opioids in patients with cancer pain. Pain Med 13(7):897–907CrossRefPubMed Corli O, Montanari M, Deandrea S, Greco MT, Villani W, Apolone G (2012) An exploratory analysis on the effectiveness of four strong opioids in patients with cancer pain. Pain Med 13(7):897–907CrossRefPubMed
20.
Zurück zum Zitat Miaskowski C, Dodd MJ, West C, Paul SM, Tripathy D, Koo P, Schumacher K (2001) Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol 19(23):4275–4279CrossRefPubMed Miaskowski C, Dodd MJ, West C, Paul SM, Tripathy D, Koo P, Schumacher K (2001) Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol 19(23):4275–4279CrossRefPubMed
21.
Zurück zum Zitat Valeberg BT, Miaskowski C, Hanestad BR, Bjordal K, Moum T, Rustoen T (2008) Prevalence rates for and predictors of self-reported adherence of oncology outpatients with analgesic medications. Clin J Pain 24(7):627–636CrossRefPubMed Valeberg BT, Miaskowski C, Hanestad BR, Bjordal K, Moum T, Rustoen T (2008) Prevalence rates for and predictors of self-reported adherence of oncology outpatients with analgesic medications. Clin J Pain 24(7):627–636CrossRefPubMed
22.
Zurück zum Zitat Graziottin A, Gardner-Nix J, Stumpf M, Berliner MN (2011) Opioids: how to improve compliance and adherence. Pain Pract 11(6):574–581CrossRefPubMed Graziottin A, Gardner-Nix J, Stumpf M, Berliner MN (2011) Opioids: how to improve compliance and adherence. Pain Pract 11(6):574–581CrossRefPubMed
23.
Zurück zum Zitat Daut RL, Cleeland CS, Flanery RC (1983) Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 17(2):197–210CrossRefPubMed Daut RL, Cleeland CS, Flanery RC (1983) Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 17(2):197–210CrossRefPubMed
24.
Zurück zum Zitat Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330(9):592–596CrossRefPubMed Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330(9):592–596CrossRefPubMed
25.
Zurück zum Zitat Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self- reported measure of medication adherence. Med Care 24(1):67–74CrossRefPubMed Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self- reported measure of medication adherence. Med Care 24(1):67–74CrossRefPubMed
26.
Zurück zum Zitat Tzeng JI, Chang CC, Chang HJ, Lin CC (2008) Assessing analgesic regimen adherence with the Morisky Medication Adherence Measure for Taiwanese patients with cancer pain. J Pain Symptom Manag 36(2):157–166CrossRef Tzeng JI, Chang CC, Chang HJ, Lin CC (2008) Assessing analgesic regimen adherence with the Morisky Medication Adherence Measure for Taiwanese patients with cancer pain. J Pain Symptom Manag 36(2):157–166CrossRef
27.
Zurück zum Zitat Schmid H, Hartmann B, Schiffl H (2009) Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature. Eur J Med Res 14(5):185–190CrossRefPubMedPubMedCentral Schmid H, Hartmann B, Schiffl H (2009) Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature. Eur J Med Res 14(5):185–190CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat McHorney CA (2009) The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin 25(1):215–238CrossRefPubMed McHorney CA (2009) The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin 25(1):215–238CrossRefPubMed
29.
Zurück zum Zitat Zhang H, Singer B (1999) Recursive partitioning in the health sciences. In: Analysis of censored data: survival trees. Springer, New York, pp 93–104 Zhang H, Singer B (1999) Recursive partitioning in the health sciences. In: Analysis of censored data: survival trees. Springer, New York, pp 93–104
30.
31.
Zurück zum Zitat Meghani SH, Thompson AM, Chittams J, Bruner DW, Riegel B (2015) Adherence to analgesics for cancer pain: a comparative study of African Americans and Whites using an electronic monitoring device. J Pain 16(9):825–835CrossRefPubMedPubMedCentral Meghani SH, Thompson AM, Chittams J, Bruner DW, Riegel B (2015) Adherence to analgesics for cancer pain: a comparative study of African Americans and Whites using an electronic monitoring device. J Pain 16(9):825–835CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Ogrodniczuk JS, Piper WE, Joyce AS (2006) Treatment compliance in different types of group psychotherapy: exploring the effect of age. J Nerv Ment Dis 194(4):287–293CrossRefPubMed Ogrodniczuk JS, Piper WE, Joyce AS (2006) Treatment compliance in different types of group psychotherapy: exploring the effect of age. J Nerv Ment Dis 194(4):287–293CrossRefPubMed
33.
Zurück zum Zitat Ktsanas D, Al-Souffi MH, Waxman BP, King RW, Polkinghorne KR, Woolley IJ (2006) Adherence to guidelines for prevention of postsplenectomy sepsis. Age and sex are risk factors: a five-year retrospective review. ANZ J Surg 76(7):542–547CrossRef Ktsanas D, Al-Souffi MH, Waxman BP, King RW, Polkinghorne KR, Woolley IJ (2006) Adherence to guidelines for prevention of postsplenectomy sepsis. Age and sex are risk factors: a five-year retrospective review. ANZ J Surg 76(7):542–547CrossRef
34.
Zurück zum Zitat Ward SE, Golberg N, Miller-McCauley V et al (1993) Patient-related barriers to management of cancer pain. Pain 52(3):319–324CrossRefPubMed Ward SE, Golberg N, Miller-McCauley V et al (1993) Patient-related barriers to management of cancer pain. Pain 52(3):319–324CrossRefPubMed
35.
Zurück zum Zitat Cohen HW, Shmukler C, Ullman R, Rivera CM, Walker EA (2010) Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c). Diabet Med 27(2):210–216CrossRefPubMedPubMedCentral Cohen HW, Shmukler C, Ullman R, Rivera CM, Walker EA (2010) Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c). Diabet Med 27(2):210–216CrossRefPubMedPubMedCentral
Metadaten
Titel
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
verfasst von
Wen-Chi Chou
Jen-Shi Chen
Chia-Yen Hung
Chang-Hsien Lu
Yu-Yun Shao
Tzeon-Jye Chiou
Yung-Chuan Sung
Kun-Ming Rau
Chia-Jui Yen
Su-Peng Yeh
Ta-Chih Liu
Ming-Fang Wu
Ming-Yang Lee
Ming-Sun Yu
Wen-Li Hwang
Pang-Yu Lai
Cheng-Shyong Chang
Ruey-Kuen Hsieh
Publikationsdatum
14.12.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4599-x

Weitere Artikel der Ausgabe 8/2019

Supportive Care in Cancer 8/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.